ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors

Luigi Fattore, Debora Malpicci, Emanuele Marra, Rosalba Camerlingo, Giuseppe Roscilli, Francesca Belleudi, Antoni Ribas, Rita Mancini, Maria Rosaria Torrisi, Luigi Aurisicchio, Paolo Antonio Ascierto, Gennaro Ciliberto

Research output: Contribution to journal › Article

Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalJournal of Translational Medicine
DOIs
Publication statusAccepted/In press - Jan 15 2015

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors. / Fattore, Luigi; Malpicci, Debora; Marra, Emanuele; Camerlingo, Rosalba; Roscilli, Giuseppe; Belleudi, Francesca; Ribas, Antoni; Mancini, Rita; Torrisi, Maria Rosaria; Aurisicchio, Luigi; Ascierto, Paolo Antonio; Ciliberto, Gennaro.

In: Journal of Translational Medicine, 15.01.2015, p. 1-2.

Research output: Contribution to journal › Article

Fattore, L, Malpicci, D, Marra, E, Camerlingo, R, Roscilli, G, Belleudi, F, Ribas, A, Mancini, R, Torrisi, MR, Aurisicchio, L, Ascierto, PA & Ciliberto, G 2015, 'ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors', Journal of Translational Medicine, pp. 1-2. https://doi.org/10.1186/1479-5876-13-S1-K3
Fattore L, Malpicci D, Marra E, Camerlingo R, Roscilli G, Belleudi F et al. ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors. Journal of Translational Medicine. 2015 Jan 15;1-2. https://doi.org/10.1186/1479-5876-13-S1-K3
Fattore, Luigi ; Malpicci, Debora ; Marra, Emanuele ; Camerlingo, Rosalba ; Roscilli, Giuseppe ; Belleudi, Francesca ; Ribas, Antoni ; Mancini, Rita ; Torrisi, Maria Rosaria ; Aurisicchio, Luigi ; Ascierto, Paolo Antonio ; Ciliberto, Gennaro. / ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors. In: Journal of Translational Medicine. 2015 ; pp. 1-2.
@article{9c1f4730619a46bfa8165ad2ec002890,
title = "ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors",
author = "Luigi Fattore and Debora Malpicci and Emanuele Marra and Rosalba Camerlingo and Giuseppe Roscilli and Francesca Belleudi and Antoni Ribas and Rita Mancini and Torrisi, {Maria Rosaria} and Luigi Aurisicchio and Ascierto, {Paolo Antonio} and Gennaro Ciliberto",
year = "2015",
month = "1",
day = "15",
doi = "10.1186/1479-5876-13-S1-K3",
language = "English",
pages = "1--2",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors

AU - Fattore, Luigi

AU - Malpicci, Debora

AU - Marra, Emanuele

AU - Camerlingo, Rosalba

AU - Roscilli, Giuseppe

AU - Belleudi, Francesca

AU - Ribas, Antoni

AU - Mancini, Rita

AU - Torrisi, Maria Rosaria

AU - Aurisicchio, Luigi

AU - Ascierto, Paolo Antonio

AU - Ciliberto, Gennaro

PY - 2015/1/15

Y1 - 2015/1/15

UR - http://www.scopus.com/inward/record.url?scp=84928732244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928732244&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-13-S1-K3

DO - 10.1186/1479-5876-13-S1-K3

M3 - Article

SP - 1

EP - 2

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

ER -

Access to Document